Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio
AbbVie (NY: ABBV)
94.18 USD  -0.05 (-0.05%)
Streaming Delayed Price  /  Updated: 10:39 AM EST, Feb 21, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,030,432
Open 93.96
Bid (Size) 94.17 (1)
Ask (Size) 94.21 (2)
Prev. Close 94.23
Today's Range 93.39 - 94.39
52wk Range 62.66 - 97.86
Shares Outstanding 1,586,879,451
Dividend Yield 3.81%
Performance
YTD
+5.17%
+5.17%
1 Month
+7.03%
+7.03%
3 Month
+8.85%
+8.85%
6 Month
+39.48%
+39.48%
1 Year
+17.74%
+17.74%
Top News
More News
AbbVie Declares Quarterly Dividend
The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.18 per share. Read More
from PR Newswire
AbbVie to Present at the Cowen 40th Annual Health Care Conference
AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Cowen 40th Annual Health Care Conference on Wednesday, March 4, 2020. Michael Severino, M.D., vice... Read More
from PR Newswire
More News
Read More
SHAREHOLDER ALERT: Monteverde & Associates PC Launches an Investigation of the Board of Directors and Officers of AbbVie Inc. - ABBV
from PR Newswire
UPDATE 3-WHO says no time for complacency as China coronavirus cases fall
category companyNews
from Reuters: Company News
UPDATE 2-WHO says no time for complacency as China coronavirus cases fall
category companyNews
from Reuters: Company News
Consumer groups, unions oppose fix for planned merger of AbbVie and Allergan
category companyNews
from Reuters: Company News
IVV, MDT, ABBV, PYPL: ETF Outflow Alert
category ETFs
from ETF Channel
Where Will Gilead Sciences Be in 10 Years?
category GILD , JNJ , GLPG , and 4 more.
from Motley Fool
17 Consumer Groups and Unions Ask FTC to Block AbbVie's Acquisition of Allergan
category AZN , ABBV , Market News , and 1 more.
from Motley Fool
Better Buy: AbbVie vs. Eli Lilly
category LLY , AGN , Market News , and 1 more.
from Motley Fool
Better Buy: AbbVie vs. Gilead Sciences
category ABBV , Market News , ABT , and 3 more.
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.